http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 27 Aug 2026 10:09:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/Press+Releases/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/PRNewswire/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/PRNewswire/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/PRNewswire/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/PRNewswire/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/PRNewswire/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/PRNewswire/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/PRNewswire/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/PRNewswire/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/PRNewswire/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/PRNewswire/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/PRNewswire/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/PRNewswire/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/PRNewswire/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/PRNewswire/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/PRNewswire/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/PRNewswire/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193 http://www.streetinsider.com/PRNewswire/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location>, <location value="LU/nl..rotter" idsrc="xmltag.org" >ROTTERDAM, Netherlands</location> and <location value="LU/cn..shangh" idsrc="xmltag.org" >SHANGHAI</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- Harbour <span>BioMed</span> (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. <person>Youchen Chen</person>, Chief Financial Officer, and Dr. <person>Ian Y. Liu</person>, Senior Vice President and Global Head of Legal, as Executive Directors of the Company, effective immediately. The appointments further strengthen the alignment between the Company's Board of Directors and management team, providing strong leadership support http://www.streetinsider.com/PRNewswire/Harbour+BioMed+Appoints+Mr.+Youchen+Chen+and+Dr.+Ian+Y.+Liu+as+Executive+Directors/26986651.html Thu, 27 Aug 2026 10:09:00 -0400 02142 2142 6XY A.00834511 A.10513256 A.18787491 A.19420966 A.31757664 A.36549092 O.00048201 O.01848302 O.02021551 O.02048399 O.04892715 O.13576167 O.34279193